Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-27 @ 12:08 PM
Study NCT ID:
NCT00884234
Status:
COMPLETED
Last Update Posted:
2020-08-28
First Post:
2009-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Sponsor:
Revance Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-17
First Submit QC Date:
None
Study First Post Date:
2009-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-09-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-08-20
Last Update Post Date:
2020-08-28
Last Update Post Date Type:
ACTUAL